Sidley represented Cellomics on the financing.Cellomics announced its Series B+ financing. The lead investor is an equity fund of a Hong Kong-listed insurance company. The previous…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now